Get the full RespiraMate company profile
Access contacts, investors, buying signals & more
RespiraMate has raised $10K in funding, the company confirmed. The round's investors and structure were not disclosed.
The startup is building a proactive asthma management tool - software aimed at helping patients stay ahead of symptoms rather than reacting to attacks. Details on how the capital will be used weren't provided.
What if the warning signs of an asthma attack could be detected before it happens? This is the question that inspired Margaret Njonjo, a The Kectil Program initiative of The Malmar Knowles Family Foundation participant and founder of RespiraMate (https://respiramate.
com). Her motivation comes from personal experience. While serving as a school sanatorium captain, she regularly helped students experiencing asthma attacks. One of the girls she assisted later passed away after an attack when she could not access her inhaler or receive help in time. Margaret decided to explore how technology could help prevent similar situations. RespiraMate is developing a smar
NewCo
NewCo Shift: A Cross-platform Publication NewCo Shift illuminates the companies, leaders, and issues driving the transition to a sustainable, positive-impact business ecosystem. In addition to the festivals, NewCo produces Shift Forum, an executive leadership conference which brings together founders, innovators, and CEOs from fast-growth start-ups and Fortune 500 leaders with an array of experts from the policy and regulation fields to discuss how business can navigate the shifting landscape of rapid technological change and regulatory uncertainty. We expand upon the conversations started at our live events through NewCo Shift, our multi-platform publication which illuminates the companies, leaders, and issues driving the transition to a sustainable, positive-impact business ecosystem. The brainchild of six-time media and tech entrepreneur John Battelle, NewCo Shift is defining a new approach to business journalism through editorial features, profiles, video, and more. It features content from notable writers and thinkers on a range of topics impacting global business today.
$1.7M Seed
today
Quadlytics Inc.
Quadlytics is building AI-powered technology to address one of the most difficult challenges in epilepsy care: seizure unpredictability. Our platform combines wearable sensing and machine learning to detect anomalous physiological changes from wearable data and provide timely insights for patients and caregivers, while supporting clinicians with relevant data for care discussions. By enabling earlier preparation and more informed decision-making, we aim to support a new model of proactive epilepsy care and help people with epilepsy live with greater confidence and independence. Our technology is currently under development and not yet available for clinical use.
Largest funding rounds in Healthcare on Signalbase right now.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Kismet Australia | Pre-seed | $42.0B | 2y ago |
| 2 |  Johnson & Johnson United States | Unknown | $7.0B |
Companies that recently closed a Unknown round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Gotham FC United States | Unknown | $100.0M | today |
| 2 |  ACTIONFIT | Unknown | $11.2M | today |
| 3 |
$3.8M Series b
today
| 2y ago |
| 3 |  Inari Medical United States | Unknown | $4.9B | 1y ago |
| 4 |  MultiPlan United States | Unknown | $4.5B | 1y ago |
| 5 |  Edwards Lifesciences United States | Unknown | $4.2B | 1y ago |
 Kalank Games France |
| Unknown |
| $1.7M |
| today |
| 4 |  EULER Canada | Unknown | $4.3M | today |
| 5 |  GimmeBirds United States | Unknown | $1.5M | today |
See who invested in RespiraMate and reach their contacts directly.
Ophthalmic Therapeutic Innovation
Recently received
Impress
Recently received
Spectral Medical Inc.
Recently received
